Business

Alexza Pharmaceuticals and Teva Pharmaceuticals USA have announced that Teva will market Adasuve loxapine inhalation powder for the treatment of agitation associated with schizophrenia or bipolar I disorder in the US. The FDA approved Adasuve in December 2012. Teva will pay Alexza $40 million up front, up to $195 million in milestone payments, and additional tiered … [Read more...] about Teva to market Alexza’s Adasuve loxapine inhalation powder in US

The 19 member companies of the Medicon Valley Inhalation Consortium (MVIC) have announced the creation of a single company called MVIC AB in order to simplify customer relationships with the organization. Orest Lastow of Zenit Design, who founded the consortium, will be CEO. MVIC AB has 2 GMP facilities and provides a full range of inhalation product services, … [Read more...] about Inhalation consortium announces formation of jointly-owned company

Israeli/American biotech company Andain Inc. says that it has developed an "innovative lipid-based drug delivery nano-particles capable of carrying hydrophilic and hydrophobic drugs to a targeted human organ with timely drug release capabilities" and announced that it has developed an inhalation solution for the treatment of COPD using the technology. The company … [Read more...] about Andain announces launch of inhaled nano-particle drug delivery technology

The board of directors of Theravance, Inc. has decided to split the organization into two separate companies by late 2013 or early 2014 in a move "designed to unlock potential value, facilitate return of capital to stockholders and further strategy of advancing medicines that address unmet medical needs," the company has announced. One company, called Theravance … [Read more...] about Theravance to split into two companies as inhalers move toward commercialization

GW Pharmaceuticals has announced that the United States Patent and Trademark Office (USPTO) has issued a Notice of Allowance in response to its patent application for a metered dose spray device for sublingual delivery of Sativex liquid cannabis extract formulation. The application serial number is 13/606,742. GW CEO Justin Gover commented, “This Notice of … [Read more...] about GW receives Notice of Allowance for patent on spray device

Galapagos subsidiary Argenta has signed an agreement with Boehringer Ingelheim to provide respiratory drug discovery services for "an undisclosed target within Boehringer Ingelheim’s respiratory disease portfolio," the company said. On its website, Argenta says that it generally expects nomination of a respiratory drug candidate within 2 years and has nominated 16 … [Read more...] about Argenta to supply respiratory drug discovery services to BI

Besins Healthcare will license the Muco (μco) intranasal system from Shin Nippon Biomedical Laboratories (SNBL) for delivery of its BHR-310 progesterone powder, which it is developing for the treatment of mild traumatic brain injury (TBI). The SNBL system includes a muco-adhesive drug carrier and a delivery device called the Fit-Lizer. Besins Chief Development … [Read more...] about SNBL licenses intranasal delivery system to Besins for intranasal progesterone

According to Celsus Therapeutics, it has received patents for several of its pipeline drugs, including MRX-4, and intranasal multifunctional anti-inflammatory drug for the treatment of allergic rhinitis. Celsus changed its name from Morria Biopharmaceuticals in March 2013. Celsus CEO Gur Roshwalb said, "We are pleased that the USPTO has issued the necessary … [Read more...] about Celsus announces patent for intranasal drug for allergic rhinitis